Shopping Cart 0
Cart Subtotal
USD 0

Bare Metal Stents (BMS) - Medical Devices Pipeline Assessment, 2018

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 2500

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 5000

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 7500
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Bare Metal Stents (BMS)-Medical Devices Pipeline Assessment, 2018

Summary

GlobalData's Medical Devices sector report, Bare Metal Stents (BMS)-Medical Devices Pipeline Assessment, 2018" provides an overview of Bare Metal Stents (BMS) currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Bare Metal Stents (BMS) pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Bare Metal Stents (BMS) under development

- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

- The report reviews the major players involved in the development of Bare Metal Stents (BMS) and list all their pipeline projects

- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

- The report provides key clinical trial data of ongoing trials specific to pipeline products

- Recent developments in the segment / industry

Reasons to buy

The report enables you to-

- Formulate significant competitor information, analysis, and insights to improve R&D strategies

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Identify and understand important and diverse types of Bare Metal Stents (BMS) under development

- Develop market-entry and market expansion strategies

- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

- In-depth analysis of the product's current stage of development, territory and estimated launch date

READ MORE

Table Of Content

Scope

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 5

1.2 List of Figures 6

2 Introduction 7

2.1 Bare Metal Stents (BMS) Overview 7

3 Products under Development 8

3.1 Bare Metal Stents (BMS)-Pipeline Products by Stage of Development 8

3.2 Bare Metal Stents (BMS)-Pipeline Products by Territory 9

3.3 Bare Metal Stents (BMS)-Pipeline Products by Regulatory Path 10

3.4 Bare Metal Stents (BMS)-Pipeline Products by Estimated Approval Date 11

3.5 Bare Metal Stents (BMS)-Ongoing Clinical Trials 12

4 Bare Metal Stents (BMS)-Pipeline Products under Development by Companies 13

4.1 Bare Metal Stents (BMS) Companies-Pipeline Products by Stage of Development 13

4.2 Bare Metal Stents (BMS)-Pipeline Products by Stage of Development 14

5 Bare Metal Stents (BMS) Companies and Product Overview 15

5.1 Advanced Bifurcation Systems Inc Company Overview 15

5.1.1 Advanced Bifurcation Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 15

5.2 AlviMedica Medical Technologies Inc. Company Overview 16

5.2.1 AlviMedica Medical Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview 16

5.3 Atrium Medical Corp Company Overview 17

5.3.1 Atrium Medical Corp Pipeline Products & Ongoing Clinical Trials Overview 17

5.4 InspireMD Inc Company Overview 18

5.4.1 InspireMD Inc Pipeline Products & Ongoing Clinical Trials Overview 18

5.5 Medtronic plc Company Overview 22

5.5.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 22

5.6 Meril Life Sciences Pvt Ltd Company Overview 23

5.6.1 Meril Life Sciences Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 23

5.7 MIV Therapeutics Inc Company Overview 25

5.7.1 MIV Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 25

5.8 Nexeon MedSystems Inc Company Overview 26

5.8.1 Nexeon MedSystems Inc Pipeline Products & Ongoing Clinical Trials Overview 26

5.9 Palmaz Scientific Inc (Inactive) Company Overview 27

5.9.1 Palmaz Scientific Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 27

5.10 Qvanteq AG Company Overview 28

5.10.1 Qvanteq AG Pipeline Products & Ongoing Clinical Trials Overview 28

5.11 Rontis AG Company Overview 29

5.11.1 Rontis AG Pipeline Products & Ongoing Clinical Trials Overview 29

5.12 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview 30

5.12.1 Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview 30

5.13 Vascular Concepts Ltd Company Overview 31

5.13.1 Vascular Concepts Ltd Pipeline Products & Ongoing Clinical Trials Overview 31

6 Bare Metal Stents (BMS)-Recent Developments 34

6.1 May 24, 2018: Medtronic Reports Fourth Quarter And Fiscal Year 2018 Financial Results 34

6.2 May 17, 2018: Mr. Jonathan Chen Promoted to Chief International Business Officer of MPSC 36

6.3 May 16, 2018: InspireMD Receives Regulatory Approval for both CGuard EPS and MGuard Prime in Ecuador 36

6.4 May 16, 2018: Surmodics Announces Leadership Change and Appointment of Interim CFO 37

6.5 May 15, 2018: Saama Technologies and ICON Commercialization and Outcomes Partner to Unlock The Value of Real World Evidence 37

6.6 May 07, 2018: Medtronic Appoints Mike Weinstein As Senior Vice President Of Strategy 38

6.7 May 02, 2018: Surmodics Reports Second Quarter Fiscal 2018 Results, Increases Fiscal 2018 Guidance 39

6.8 May 02, 2018: CORRECTING and REPLACING Surmodics Reports Second Quarter Fiscal 2018 Results, Increases Fiscal 2018 Guidance 40

6.9 May 02, 2018: ICON Reports First Quarter 2018 Results 41

6.10 Apr 30, 2018: InspireMD Announces Regulatory Approval and Reimbursement to Commercialize both CGuard EPS and MGuard Prime Products in Vietnam 42

6.11 Apr 25, 2018: Boston Scientific Reports Financial Results For First Quarter 2018 42

6.12 Apr 20, 2018: Cook Medical Appoints Christina Anne Vice President of Distribution Channel Management 44

6.13 Apr 19, 2018: B. Braun Interventional Systems Launches Expanded CP Stent Portfolio in Collaboration with NuMED 45

6.14 Apr 18, 2018: Abbott Reports First-Quarter 2018 Results 45

6.15 Apr 12, 2018: STENTYS: Financial Information for the First Quarter of 2018 48

6.16 Apr 05, 2018: Dr. Laura Mauri to Join Medtronic as Vice President, Global Clinical Research & Analytics 48

6.17 Mar 28, 2018: MicroPort Scientific Announces 2017 Annual Results 49

6.18 Mar 27, 2018: InspireMD Receives Regulatory Approval for both CGuard EPS and MGuard Prime in Peru 51

6.19 Mar 27, 2018: MicroPort Scientific Announces Year Ended 31 December 2017 Financial Results 52

6.20 Mar 23, 2018: 2017 fiscal year: B. Braun increases sales and earnings, with investments of one billion euros 52

6.21 Mar 14, 2018: ICON opens a new office in Boston 54

6.22 Feb 15, 2018: ICON Reports Fourth Quarter and Full Year 2017 Results 55

6.23 Feb 13, 2018: Four start-ups chosen for the B. Braun Accelerator Program 57

6.24 Feb 08, 2018: MicroPort Signs Strategic Agreement with Neptunus Biotechnology 57

6.25 Feb 08, 2018: Surmodics Reports First Quarter Fiscal 2018 Results, Updates Fiscal 2018 Guidance 58

6.26 Feb 01, 2018: Boston Scientific Announces Results for Fourth Quarter and Full Year 2017 59

6.27 Jan 30, 2018: Alex Gu Named Senior Vice President and President of Medtronic's Greater China Region 61

6.28 Jan 25, 2018: First Patient Enrolled in Tryton Post Approval Study 61

6.29 Jan 24, 2018: Positive results for TPS in breast cancer study performed in Czech Republic 62

6.30 Jan 24, 2018: Abbott Reports Fourth-Quarter 2017 Results 62

6.31 Jan 09, 2018: MicroPort Selected as "2017 China Innovative Medical Device Company" 65

6.32 Jan 09, 2018: MicroPort Awarded 2017 Shanghai Pilot Enterprise with Outstanding Innovation 66

6.33 Jan 09, 2018: Boston Scientific Announces Preliminary Unaudited Sales For The Fourth Quarter And Full Year Ended December 31, 2017 67

6.34 Jan 09, 2018: ICON Appoints Dr. James Cummings as President of ClinicalRM 67

6.35 Jan 08, 2018: STENTYS Reports Revenues for the Fourth Quarter and Full Year 2017 67

7 Appendix 108

7.1 Methodology 108

7.2 About GlobalData 111

7.3 Contact Us 111

7.4 Disclaimer 111


List Of Figure

1.2 List of Figures

Figure 1: Bare Metal Stents (BMS)-Pipeline Products by Stage of Development 8

Figure 2: Bare Metal Stents (BMS)-Pipeline Products by Territory 9

Figure 3: Bare Metal Stents (BMS)-Pipeline Products by Regulatory Path 10

Figure 4: Bare Metal Stents (BMS)-Pipeline Products by Estimated Approval Date 11

Figure 5: Bare Metal Stents (BMS)-Ongoing Clinical Trials 12


List Of Table

1.1 List of Tables

Table 1: Bare Metal Stents (BMS)-Pipeline Products by Stage of Development 8

Table 2: Bare Metal Stents (BMS)-Pipeline Products by Territory 9

Table 3: Bare Metal Stents (BMS)-Pipeline Products by Regulatory Path 10

Table 4: Bare Metal Stents (BMS)-Pipeline Products by Estimated Approval Date 11

Table 5: Bare Metal Stents (BMS)-Ongoing Clinical Trials 12

Table 6: Bare Metal Stents (BMS) Companies-Pipeline Products by Stage of Development 13

Table 7: Bare Metal Stents (BMS)-Pipeline Products by Stage of Development 14

Table 8: Advanced Bifurcation Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 15

Table 9: Stenting System-Bare Metal Stent-Product Status 15

Table 10: Stenting System-Bare Metal Stent-Product Description 15

Table 11: AlviMedica Medical Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview 16

Table 12: BMS-Avantgarde-Product Status 16

Table 13: BMS-Avantgarde-Product Description 16

Table 14: Atrium Medical Corp Pipeline Products & Ongoing Clinical Trials Overview 17

Table 15: Next Generation Super Flexible Cobalt Chromium Coronary Stent-Product Status 17

Table 16: Next Generation Super Flexible Cobalt Chromium Coronary Stent-Product Description 17

Table 17: InspireMD Inc Pipeline Products & Ongoing Clinical Trials Overview 18

Table 18: MGuard Prime EPS-Product Status 18

Table 19: MGuard Prime EPS-Product Description 19

Table 20: InspireMD Inc-Ongoing Clinical Trials Overview 20

Table 21: MGuard Prime EPS-Long Term Outcomes of MGuard Stent Deployment in Saphenous Vein Grafts and Native Coronary Arteries 21

Table 22: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 22

Table 23: Twin-Rail-Product Status 22

Table 24: Twin-Rail-Product Description 22

Table 25: Meril Life Sciences Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 23

Table 26: Crypton Stainless Steel Coronary Stent System-Product Status 23

Table 27: Crypton Stainless Steel Coronary Stent System-Product Description 23

Table 28: NEXGEN Cobalt Chromium Coronary Stent System-Product Status 24

Table 29: NEXGEN Cobalt Chromium Coronary Stent System-Product Description 24

Table 30: MIV Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 25

Table 31: Vestapor-Product Status 25

Table 32: Vestapor-Product Description 25

Table 33: Nexeon MedSystems Inc Pipeline Products & Ongoing Clinical Trials Overview 26

Table 34: PROTEX Coronary Stent System-Product Status 26

Table 35: PROTEX Coronary Stent System-Product Description 26

Table 36: Palmaz Scientific Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 27

Table 37: Micro-Grooved Coronary Stent-Product Status 27

Table 38: Micro-Grooved Coronary Stent-Product Description 27

Table 39: Qvanteq AG Pipeline Products & Ongoing Clinical Trials Overview 28

Table 40: Qstent Coronary Stent System-Product Status 28

Table 41: Qstent Coronary Stent System-Product Description 28

Table 42: Rontis AG Pipeline Products & Ongoing Clinical Trials Overview 29

Table 43: Bifurcation Stent System-Product Status 29

Table 44: Bifurcation Stent System-Product Description 29

Table 45: Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview 30

Table 46: Bare Metal Coronary Stent-Product Status 30

Table 47: Bare Metal Coronary Stent-Product Description 30

Table 48: Vascular Concepts Ltd Pipeline Products & Ongoing Clinical Trials Overview 31

Table 49: ProLink LP-Product Status 31

Table 50: ProLink LP-Product Description 31

Table 51: ProLink SV-Product Status 32

Table 52: ProLink SV-Product Description 32

Table 53: ProPass-Product Status 32

Table 54: ProPass-Product Description 33

Table 55: ProZeta-Product Status 33

Table 56: ProZeta-Product Description 33

Table 57: Glossary 110

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

dvanced Bifurcation Systems Inc, Stenting System - Bare Metal Stent; AlviMedica Medical Technologies Inc., BMS - Avantgarde; Atrium Medical Corp, Next Generation Super Flexible Cobalt Chromium Coronary Stent; InspireMD Inc, MGuard Prime EPS; Medtronic plc, Twin-Rail; Meril Life Sciences Pvt Ltd, Crypton Stainless Steel Coronary Stent System; Meril Life Sciences Pvt Ltd, NEXGEN Cobalt Chromium Coronary Stent System; MIV Therapeutics Inc, Vestapor; Nexeon MedSystems Inc, PROTEX Coronary Stent System; Palmaz Scientific Inc (Inactive), Micro-Grooved Coronary Stent; Qvanteq AG, Qstent Coronary Stent System; Rontis AG, Bifurcation Stent System; Sree Chitra Tirunal Institute for Medical Sciences &; Technology, Bare Metal Coronary Stent; Vascular Concepts Ltd, ProLink LP; Vascular Concepts Ltd, ProLink SV; Vascular Concepts Ltd, ProPass; Vascular Concepts Ltd, ProZeta


Companies

Advanced Bifurcation Systems Inc

AlviMedica Medical Technologies Inc.

Atrium Medical Corp

InspireMD Inc

Medtronic plc

Meril Life Sciences Pvt Ltd

MIV Therapeutics Inc

Nexeon MedSystems Inc

Palmaz Scientific Inc

Qvanteq AG

Rontis AG

Sree Chitra Tirunal Institute for Medical Sciences & Technology

Vascular Concepts Ltd